TY - JOUR
T1 - Purinergic receptors involved in the immunomodulatory effects of ATP in human blood
AU - Swennen, E.L.R.
AU - Bast, A.
AU - Dagnelie, P.C.
PY - 2006/1/1
Y1 - 2006/1/1
N2 - We recently showed that the physiological compound ATP simultaneously inhibited TNF-alpha and stimulated IL-10 release in LPS-PHA stimulated blood. The purpose of the present study was to determine the mechanism involved in the concerted modulatory effect of ATP on TNF-alpha and IL-10. Incubation of blood with ATP in the presence of selective P2 receptor antagonists showed that the stimulatory effect of ATP on IL-10 release was completely annihilated by both 2-MeSAMP (a P2Y(12/13) receptor antagonist) and PSB-0413 (a P2Y(12) receptor antagonist). On the other hand, the inhibitory effect of ATP on TNF-alpha release was completely reversed by 5'-AMPS (a P2Y(11) receptor antagonist) as well as by H-89, an inhibitor of cAMP-activated PKA. The concerted inhibition by ATP of TNF-alpha release via P2Y(11) activation and stimulation of IL-10 release via P2Y(12) activation implicates a novel approach towards immunomodulation by altering the balance among pro- and anti-inflammatory cytokines. AD - Department of Pharmacology and Toxicology, NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands; Department of Epidemiology, NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
AB - We recently showed that the physiological compound ATP simultaneously inhibited TNF-alpha and stimulated IL-10 release in LPS-PHA stimulated blood. The purpose of the present study was to determine the mechanism involved in the concerted modulatory effect of ATP on TNF-alpha and IL-10. Incubation of blood with ATP in the presence of selective P2 receptor antagonists showed that the stimulatory effect of ATP on IL-10 release was completely annihilated by both 2-MeSAMP (a P2Y(12/13) receptor antagonist) and PSB-0413 (a P2Y(12) receptor antagonist). On the other hand, the inhibitory effect of ATP on TNF-alpha release was completely reversed by 5'-AMPS (a P2Y(11) receptor antagonist) as well as by H-89, an inhibitor of cAMP-activated PKA. The concerted inhibition by ATP of TNF-alpha release via P2Y(11) activation and stimulation of IL-10 release via P2Y(12) activation implicates a novel approach towards immunomodulation by altering the balance among pro- and anti-inflammatory cytokines. AD - Department of Pharmacology and Toxicology, NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands; Department of Epidemiology, NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
U2 - 10.1016/j.bbrc.2006.07.177
DO - 10.1016/j.bbrc.2006.07.177
M3 - Article
C2 - 16904065
SN - 0006-291X
VL - 348
SP - 1194
EP - 1199
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -